+91 84258 80640 export@saliuspharma.com

Product Overview

Dipyridamole ER (Extended Release) Coated Pellets are specialized multiarticulate dosage forms designed for sustained release of Dipyridamole, a platelet aggregation inhibitor and vasodilator. These pellets are intended for use in the formulation of capsules or tablets, providing controlled and prolonged therapeutic action.

Acetaminophen DC Granules – Typical Composition

Component Function
Dipyridamole Active Pharmaceutical Ingredient (API)
Sugar Spheres / MCC Spheres Inert core or starter pellets
Hydroxypropyl Methylcellulose (HPMC) Binder / Film former during layering
Talc / Colloidal Silicon Dioxide Anti-adherent / Glidant
Eudragit RS / Eudragit RL Extended-release polymer (controls drug release rate)
Triethyl Citrate / PEG 6000 Plasticizer (for coating)
Purified Water Solvent (removed after processing)

Why Choose Pellets from Salius Pharma?

Outsourcing pellets through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance. Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.

Key Advantages of Partnering with Salius Pharma

Expected Delivery Time

We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.

Place an Order or Request a Quote from Salius Pharma

Looking to source Dipyridamole ER Coated or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.

Get in Touch

Confidentiality Notice

The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.

Any patented products are excluded from our offerings in regions where such patents are currently in force.

FAQs

Dipyridamole ER Coated Pellets are used in the formulation of extended-release capsules or tablets, mainly for the prevention of thromboembolic complications and as an adjunct in cardiovascular therapies.

Yes. They are often used in fixed-dose combinations (e.g., with Aspirin) to enhance antiplatelet efficacy and provide synergistic therapeutic benefits.

Dipyridamole ER Coated Pellets are typically tested as per USP, BP, and EP pharmacopoeia standards, with validated HPLC methods for identification and assay.

Yes. Technical documentation, dissolution profiles, and formulation guidance can be provided to support product registration and development.

Send Enquiry
Chat With Us!
Call Us!
Mail Us!